Predicate |
Object |
contentType |
Journal Article|Research Support, N.I.H., Extramural|Comment |
endingPage |
602 |
issn |
1387-2877 1875-8908 |
issueIdentifier |
2 |
pageRange |
599-602 |
publicationName |
Journal of Alzheimer's disease : JAD |
startingPage |
599 |
hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 |
isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0ff5859bf6fbb0f867808edddf5df4eb http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fbf205ee316b679fee29721b59de9778 |
bibliographicCitation |
Norris CM. Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia? J Alzheimers Dis. 2023;95(2):599–602. doi: 10.3233/jad-230780. PMID: 37661889. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88a1130d4cbc1d9008999617d8d5a7e7 |
date |
2023-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/37661889 https://doi.org/10.3233/jad-230780 |
isPartOf |
https://portal.issn.org/resource/ISSN/1387-2877 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 https://portal.issn.org/resource/ISSN/1875-8908 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia? |
discusses |
http://id.nlm.nih.gov/mesh/M0025261 http://id.nlm.nih.gov/mesh/M0587252 http://id.nlm.nih.gov/mesh/M0011171 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000544 http://id.nlm.nih.gov/mesh/D060825Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D007166Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D065095Q000627 http://id.nlm.nih.gov/mesh/D016559Q000627 |